Journals / Viral Hepatitis Journal / 2015 / Cilt: 21 - Sayı: 2

Vitamin D Düzeyleri ve Kronik Hepatit B: Bir İlişki Var mı?

Vitamin D Levels and Hepatitis B: Is There Any Relationship?

Pages
44–47
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Prospective, well-designed and controlled studies are needed to show its effect on the course of chronic hepatitis B.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: It has been shown that vitamin D has very important biologic effects including cell differentiation, inhibition of proliferation and immune modulation.
📊
Key Findings & Data:Materials and Methods: Patients who were admitted to the infectious diseases outpatient clinic with chronic HBV infection between January and March 2013 were enrolled as cases.
💡
Conclusion & Impact:Prospective, well-designed and controlled studies are needed to show its effect on the course of chronic hepatitis B.
🔬Design:Research Article
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: It has been shown that vitamin D has very important biologic effects including cell differentiation, inhibition of proliferation and immune modulation. Vitamin D levels may affect the immune system and host response to viral infections, such as hepatitis B virus (HBV) infection. Our aim in this study was to see whether or not there is a relationship between vitamin D levels and chronic HBV infection. Materials and Methods: Patients who were admitted to the infectious diseases outpatient clinic with chronic HBV infection between January and March 2013 were enrolled as cases. Controls were chosen randomly among individuals admitted to the outpatient clinic at the same time period and otherwise healthy. Results: Ninety chronic HBV cases and 76 controls were included in the period of study. Thirty-three (42.2%) of the control and 39 (43.3%) of the case groups were male. The mean age and vitamin D levels of the case and control groups were; 39.9±13.3 years, 43.0±13.3 years and 11.7±6.6 ng/ml, 16.2±8.7 ng/ml, respectively. Vitamin D levels were significantly lower in the case group (p<0.001). There was no significant difference in vitamin D levels between the treatment- free group and treatment group (14.0±6.9 ng/ml, 11.0±6.3 ng/ml, respectively; p>0.05). There was no correlation between HBV DNA and vitamin D levels. Conclusion: Vitamin D levels were found to be lower in chronic HBV patients in our study which was designed as case-control. Prospective, well-designed and controlled studies are needed to show its effect on the course of chronic hepatitis B.

Özet

Amaç: Yapılan çalışmalar sonucunda vitamin D’nin hücre farklılaşması, proliferasyonun inhibisyonu ve immun modulasyon gibi çok önemli biyolojik etkilerinin olduğu gösterilmiştir. Vitamin D düzeylerinin, hepatit B virüs (HBV) enfeksiyonu gibi viral enfeksiyonlara karşı immün sistem ve konak yanıtını etkileyebileceği düşünülmektedir. Bu çalışmanın amacı vitamin D düzeyleri ve kronik HBV enfeksiyonu arasında ilişki olup olmadığını araştırmaktır. Gereç ve Yöntemler: Hastanemiz Enfeksiyon Hastalıkları polikliniğine kronik HBV enfeksiyonu tanısıyla Ocak ve Mart 2013 tarihleri arasında başvuran hastalar çalışmaya dahil edilmiştir. Kontrol grubu olarak aynı zaman aralığında polikliniğe başvuran ve kronik herhangi bir hastalığı olmayan hastalar alınmıştır. Bulgular: Doksan hasta ve 76 kontrol hastası, çalışmaya dahil edildi. Kontrol grubunun 33’ü (%42,2) ve olgu grubunun 39’u (%43,3) erkekti. Olgu ve kontrol grubunun ortalama yaş ve vitamin D düzeyleri sırasıyla; 39,9±13,3 yıl ile 43,0±13,3 yıl ve 11,7±6,6 ng/ml ile 16,2±8,7 ng/ml idi. Vitamin D düzeyleri olgu grubunda anlamlı derecede düşüktü (p 0,05). HBV DNA ve vitamin D düzeyleri arasında bir korelasyon tespit edilmedi. Sonuç: Olgu-kontrol düzeni ile tasarlamış olduğumuz bu çalışmada vitamin D düzeyleri kronik HBV’li hastalarda daha düşük bulunmuştur. Vitamin D’nin kronik HBV seyri üzerindeki etkisini net olarak gösterebilmek için daha detaylı tasarlanmış, prospektif ve kontrollü çalışmalara ihtiyaç vardır.

🔖

Cite This Article

CANDEVİR, A. U., KUŞCU, F., İNAL, A. S., KÖMÜR, S., KURTARAN, B., NAZİK, S., TAŞOVA, Y., AKSU, H. S. Z. (2015). Vitamin D Düzeyleri ve Kronik Hepatit B: Bir İlişki Var mı?. Viral Hepatitis Journal, Cilt: 21 - Sayı: 2, 44–47. https://ajindex.com/articles/332700

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. McMahon BJ. Chronic hepatitis B virus infection. Med Clin North Am. 2014; 98: 39-54
  2. Lai CL, Ratziu V, Yuen MF, Poynard T. Viral hepatitis B. Lancet. 2003; 362(9401):2089-2094
  3. Ganem D, Prince AM. Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med. 2004; 350: 1118- 1129
  4. Kitson MT, Roberts SK. D-livering the message: the importance of vitamin D status in chronic liver disease. J Hepatol. 2012; 57: 897-909
  5. Loke H, Bethell D, Phuong CX, Day N, White N, Farrar J, Hill A. Susceptibility to dengue hemorrhagic fever in vietnam: evidence of an association with variation in the vitamin d receptor and Fc gamma receptor IIa genes. Am J Trop Med Hyg. 2002; 67: 102-106
  6. Holmoy T. Vitamin D status modulates the immune response to Epstein Barr virus: Synergistic effect of risk factors in multiple sclerosis. Med Hypotheses. 2008; 70: 66-69
  7. Sorenson OE, Follin P, Johnsen A, Calafat J, Tjabringa GS, Himestra PS, Borrenqaard N. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleaveage with proteinase 3. Blood. 2001; 97: 3951-3959
  8. Bergmana P, Walter-Jallow L, Broliden K, Agerberth B, Söderlund J. The antimicrobial peptide LL-37 inhibits HIV-1 replication. Curr HIV Res. 2007; 5: 410-415
  9. Beard JA, Bearden A, Striker R.Vitamin D and the anti-viral state. J ClinVirol. 2011; 50: 194-200
  10. Bitetto D, Fabris C, Fornasiere E, Pipan C, Fumolo E, Cussigh A, Bignulin S, Cmet S, Fontanini E, Falleti E, Martinella R, Pirisi M,Toniutto P. Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C. Transpl Int. 2011; 24: 43-50
  11. Petta S, Cammà C, Scazzone C, Tripodo C, Di Marco V, Bono A, Cabibi D, Licata G, Porcasi R, Marchesini G, Craxí A. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology. 2010; 51: 1158-1167
  12. Bals R, Wilson JM. Cathelicidins- a family of multifunctional antimicrobial peptides. Cell Mol Life Sci. 2003; 60: 711-720
  13. Eisman JA. Vitamin D receptor gene variants: implication for therapy. Curr Opin Genet Dev. 1996; 6: 361-365
  14. Bellamy R, Ruwende C, Corrah T, McAdam KP, Thursz M, Whittle HC, Hill AV. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J Infect Dis. 1999; 179: 721-724
  15. Demir C, Demir M. Vitamin D levels in patients with chronic hepatitis B